List Title | APhA DrugInfoLine

Infectious Diseases

SORT BY: Most Recent Most Viewed

February 1, 2008

Multidrug-resistant, community-associated MRSA clone USA300 more common among men who have sex with men

READ

PREVIEW
A recently identified community-associated strain of methicillin-resistant Staphylococcus aureus (MRSA) that carries multiple resistance genes—known as multidrug-resistant USA300...
November 1, 2007

U.S. burden of invasive MRSA infections: Public health problem

READ

PREVIEW
The incidence of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections in the United States is higher than previously projected; an estimated 94,360 invasive MRSA...
September 1, 2007

Zinc therapy for the common cold: Sparse evidence

READ

PREVIEW
A structured review of studies that examined the effect of zinc therapy for the treatment of the common cold found little evidence for its effectiveness.
May 1, 2007

Guidelines on management of community-acquired pneumonia: 2007 update

READ

PREVIEW
The Infectious Diseases Society of America (IDSA) and American Thoracic Society (ATS) have developed a unified guideline on the management of community-acquired pneumonia (CAP). Primary...
October 1, 2006

MRSA: A public health threat everywhere

READ

PREVIEW
Methicillin-resistant Staphylococcus aureus (MRSA) is responsible for a worldwide pandemic. In a recent article, Grundmann et al. recommended a comprehensive MRSA-control program that...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.